Peripheral sensory neuropathy is one of the most common long term complications of diabetes mellitus occurring in about 50% ofpatients with diabetes of25 years duration.' A careful history and physical examination documenting pain and paraesthetic symptoms and impairment of pain, temperature, vibratory, and light touch sensation is the cornerstone of diagnosis of this condition. However, quantitative criteria are necessary to permit comparative distinctions to be made in serial follow-up of individual patients. The need is made more imperative by the advent of clinical trials of aldose reductase inhibitors and other agents with the potential of improving and even reversing symptomatic diabetic neuropathy. We have compared current perception thresholds (CPTs) with nerve conduction velocities (NCVs) as parametric indicators of diabetic sensory neuropathy.
Nerve conduction testing (NCT) is the classical technique used for diagnosis of diabetic neuropathy. The diagnostic interpretation of the compound action potentials evoked in the standard NCT includes the analysis of changes in sensory and motor nerve conduction velocities (NCVs), response amplitudes, and latencies. Of these measurements, NCVs are the most reproducible and subject to standardisation. Therefore NCVs have become the quantitative hallmark of the extent and progression of impairment in diabetic peripheral neuropathy.27 However, the degree of correlation between NCVs and the clinically observable parameters of severity of diabetic sensory neuropathy has never been established. The question 502
Nerve conduction velocities and current perception thresholds as correlates ofseverity ofdiabetic neuropathy 503 is: how well do NCVs reflect the symptoms ofpain and numbness and the loss of physical sensation which characterise diabetic sensory neuropathy? The standard measurement of peripheral nerve conduction velocity is largely determined by the state of the largest, most rapidly conducting myelinated fibres. 8 However, the pathophysiological lesions of diabetic neuropathy involve a broad spectrum of nerve fibres of varying diameter, with coexisting processes of demyelination and remyelination.'2 Painful diabetic sensory neuropathy, in particular, is related more specifically to changes in unmyelinated and small myelinated fibres.'3 Therefore, there is considerable uncertainty that NCVs adequately represent the pathological and clinical changes of diabetic sensory peripheral neuropathy. '4 CPT testing is relatively new in the assessment of sensory neuropathy, although the perception of electrical stimulation of sensory nerves with skin electrodes is not.' " Physiologically, current perception appears to represent direct stimulation of myelinated and unmyelinated nerve fibres in the skin."-35 Nerve conduction testing uses supramaximal stimuli, thereby recruiting all available fibres, and therefore assesses whole nerve bundle conduction more than individual fibre integrity. In contrast, CPT testing relies on minimal stimuli and thus is dependent on local integrity of nerve endings as well as conduction. Electrocutaneous perception seems to correlate best with the applied current rather than the voltage.'7'9 However, the reproducible application of current requires standardisation of skin impedance,'12' which is difficult to achieve since skin resistance and impedance vary considerably with applied current."-32 These variations previously made it difficult to quantitatively relate applied current to sensory threshold. However, the recent deve.,.pment of a multiple frequency alternating current viewed to eliminate any potential interfering neurological conditions. Exclusion factors included a significant history of alcohol ingestion, thyroid disease, symptoms suggestive of cervical or lumbar disc disease or nerve root irritation, occupational exposure to neurotoxins, or history of significant trauma potentially damaging to peripheral innervation. Any patient with a serum creatinine greater than 2-0 mg/dl or abnormal serum vitamin B12 or VDRL levels was excluded from the study. All patients requiring treatment of their neuropathy with anything other than a non-narcotic analgesic were excluded from the study.
Clinical Evaluation: Assessments were carried out by one examiner. A second examiner carried out independent evaluations without prior knowledge for verification. The historica! evaluation was adapted (so as to focus very specifically on sensory complaints) from the Neurological Symptom Score (NSS) proposed by Dyck et ap'2 for evaluation ofperipheral neuropathy. Patients were questioned as to symptoms on the upper and lower extremities. They were asked to describe their symptoms as either painful or nonpainful with further breakdown of pain into "burning," "deep aching," "shooting," "tenderness," or other pain.
Non-painful symptoms were "numbness," "asleep feeling," prickling," "tingling," "pins and needles," or other paraesthesiae. Inability to maintain balance or carry out fine activities due to lack of feeling were indicative of loss of proprioception. They were carefully questioned as to the severity oftheir symptoms, characterising each complaint as either absent (Grade 0), mild (1-2), moderate (3) (4) (5) (6) , severe (7) (8) , or very severe (9, 10). The examiner asked further questions to confirm the patient's perception of severity, including whether the pain kept the patient up at night, whether contact such as bed covers could be tolerated, if pain medication was used, or ifthe patient had been burned or injured as a result of absence of aversive perception. The examiner then assigned the final grade to each symptom and separately characterised the symptomatic score (SS) for the upper extremity and for the lower extremity on a scale of 0 to 10.
The neurologic physical examination was carried out in standard fashion as described in the Neurological Disability Score physical score (PS) for upper and lower extremities was calculated by adding the scores for the four sensory modalities at each site on the patient's left side. Any patient with significant asymmetry on the clinical examination was excluded from further study. The neurological physical examinations were characterised for upper and lower extremities as either normal, mildly abnormal, moderately abnormal, or severely abnormal. Normal was defined as a total score of 0. Mild abnormality was defined as no greater than a 2 + impairment on the finger tips or toes and no more than a 1 + impairment on distal and proximal halves of hand or foot, thus corresponding to a PS no greater than 16. Severe abnormality was characterised as total absence of perception to the four physical modalities on the upper extremity at least up to the wrist or, on the lower extremity, at least up to the ankle. This corresponded to a total PS of at least 48. Moderate abnormality was classified as a PS between 17 and 47. Nerve Conduction Testing: Nerve conduction testing was carried out on each subject's left side using standard techniques.43 A Cavan Model 600 dual channel electromyograph was used. A supramaximal stimulus of 100 to 300 volts of 0 1 to 0 5 ms duration was applied using surface electrodes at a frequency of 1/s. Motor conduction velocities were determined for the median nerve (NCVM), the ulnar nerve (NCVU), the tibial (NCVTIB) and peroneal nerves (NCV-PER), calculated by dividing the distance between proximal and distal stimulating cathodes by the latency. Sensory potentials were calculated by dividing the distance between stimulating and recording cathodes by response latency. The results were calculated on the basis of average of ten or more responses. The median sensory nerve conduction velocity (NCSMED) was obtained using orthodromic stimulation, and the sural sensory nerve velocity (NCS) using antidromic stimulation. Skin temperature was maintained using infrared heating or warming blankets between 33' and 35°C, determined using specially designed liquid crystal thermometers Rendell, Katims, Richter, Rowland (Seven Cs, St. Louis, Missouri), with accurate gradations of 0 5C positioned on several places on arm or leg. Nerve conduction testing is subject to significant variability, despite the standardisation of procedures. Whenever possible, nerve conduction velocities were repeated twice within three days and the averaged values taken as the result. Vibration Threshold Testing: The technique was as originally described by Goldberg and Lindblom.' The vibratory threshold was determined at three sites on the left side: (a) the dorsum of the second metacarpal (carpal site, VCAR), (b) the flat surface of the proximal part of the tibia (tibial plateau, VTIB), and (c) the dorsomedial aspect of the first metatarsal bone (tarsal site, VTAR). The vibration testing device (Biothesiometer, Bio-Medical Instruments, Newbury, Ohio) was hand applied to each site with the pressure of its own weight (450 g). The vibration threshold (VT) was determined by the method of limits. Stimulus strength was incremented gradually from zero to the point where sensation was first perceived (vibration perception threshold measured in millivolts). The stimulus was then decreased to the point where the sensation first disappeared (vibration disappearance threshold). This procedure was repeated three times. The average of the three perception and disappearance thresholds was calculated as the VT. The current was delivered to the skin surface via a pair of I cm diameter standard carbon electrodes separated by 1-7 cm. A light covering of standard electrode paste applied to the electrode was used as a conducting medium between the electrodes and the underlying skin. Care was taken to ensure that only the skin directly underlying each electrode was in contact with the paste while the surrounding skin areas remained dry with no electrode paste.
Two test stimulation sites on the left side were selected: the dorsal surfaces of the distal phalanges of the index finger and the great toe. Each subject was seated in a quiet area and asked to concentrate on the testing procedure. At each frequency, the current was progressively incremented until the subject could first perceive the sensation. The current was then rapidly decreased and increased until the same threshold measure was obtained on at least five consecutive trials to establish the threshold. The result was also verified with placebo stimulation by turning off all current, unknown to the patient, to challenge the patient's reported sensation at threshold, a procedure known as "forced choice". The thresholds on the hand at the three frequencies are named H5, H250, and H2000, those on the foot, FT5, FT250, and FT2000. Statistical Analysis: Neurological examinations were carried out together with electrodiagnostic testing initially and repeated sequentially at intervals in consenting participants. Each evaluation was treated as an independent event with no reference to prior measures. Non-parametric correlation analysis (Spearman rho) was performed as a measure of Nerve conduction velocities and current perception thresholds as correlates ofseverity ofdiabetic neuropathy 505 association45 of symptom and physical scores with the various electrodiagnostic variables. Class comparisons were carried out using non-parametric analysis of variance (Kruskal-Wallis). Values for each electrodiagnostic parameter were classified as either within the normal range (Class I) or abnormal (Class II). In order to evaluate the contribution of highly abnormal or unobtainable electrodiagnostic measures, the abnormal range was subdivided by defining an arbitrary limit for "very abnormal values". For NCVs, this limit was defined as 10 m/s or more below the lower end of the normal range. VTs greater than 35 volts and CPTs greater than 9 mAmp were similarly classified. All unobtainable measures were assigned to the "very abnormal" group (Class Ilb).
Results
There were 71 individuals who participated in this study, 36 men, average age 51, SD 3, and 35 women, average age 54, SD 2 years. This group underwent 169 comprehensive evaluations consisting of a neurological history and physical examination, nerve conduction testing, CPT, and VT measurements. There were 36 persons who had multiple serial comprehensive evaluations. Of this group, 28 underwent repeated evaluations 2, 6, 10, and 12 months after the initial evaluation. Repeat assessments in time were treated as fully independent events, without reference to previous evaluations.
The study population exhibited a wide spectrum of severity of sensory neuropathy, classified as being of either normal, mild, moderate, or severe degree on the basis of detailed grading of symptoms and physical exam (table 2) . Generally physical findings were relatively more severe than symptomatic reports, and both tended to be more severe for the lower extremity than for the upper extremity. Classified either on the basis ofsymptomatic or physical findings, the majority of evaluations were in the "mild" or "moderate" categories on the upper extremity while falling into the "moderate" or "severe" categories on the lower extremity. This is in keeping with the usual stocking predominance of diabetic neuropathy.
The correlation of symptoms on upper and lower extremities (Spearman rho = 0 65) was better than the cross correlations of symptoms with physical findings on either upper or lower extremity (table 3) . Similarly, the correlation ofphysical findings on upper and lower extremities (0-63) was better than the cross correlations. Correlations with glycohaemoglobin values were weak.
Spearman correlation coefficients between the NCVs and the SS and PS on upper and lower extremities are presented in table 4 . Although most correlations were significant, the coefficients were relatively weak, particularly for the correlations of symptom scores with the motor NCVs. The sensory NCVs correlated somewhat better with symptom scores than with physical scores.
Both vibration thresholds and CPTs showed better correlations with the PS than with the SS on both upper and lower extremities (table 5) , and correlation coefficients were generally higher than for NCVs. The highest correlations were exhibited between the CPT values and the PS on the lower extremity, with rho values greater than 0 5. Correlations of VTs with PS were higher than the corresponding NCV correlations, but generally less than the CPT correlations. On the lower extremity, there was not a significant correlation between VTs and SS.
Although significant, the degrees of correlation between NCVs and clinical scores did not appear to be sufficient to create adequate distinctions of level of clinical impairment. In particular, NCVs in the normal range were present in patients with both marked symptoms and physical findings of sensory neuropathy, and abnormal NCVs were not necessarily accompanied by significant clinical abnormalities. The SS and PS corresponding to normal NCV values (Class I) were compared to SS and PS corresponding to abnormal values (Class II). On the upper extremity (table 6) , clinical scores were poorly separated by the two NCV classes. Symptom scores did not show any significant differences. There was a small difference On the lower extremity, the same tendency prevailed (table 7) . NCVs were not very effective discriminators of either symptom or physical scores. Even though NCVTIB did show a significant separation of physical scores, the mean PS for Class I was 38, SD 4, a very high value in the range of moderate impairment, compared to the Class II score of49, SD 2. In contrast, CPTs were considerably more effective. Again the Spearman correlation coefficients were calculated for the relationships of the lower and upper extremity symptom and physical scores and the given CPTs and VTs. H5, H250, and H2000 are the CPTs for 5, 250, and 2000 Hz on the index finger, FT5, FT250, and FT2000 are the corresponding CPTs on the large toe. VCAR is the VT on the first metacarpal, VTIB, the VI on the tibial plateau, and VTAR the VT on the first metatarsal bone. *p < 0-05; tp < 001; $p < 0 001.
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It could be argued that our class comparisons were skewed by a large proportion of very abnormal or unobtainable measures for certain electrodiagnostic parameters. To exclude this possibility, the clinical score comparisons were repeated, subdividing abnormal NCVs, CPTs, and VTs into "relatively abnormal" (Class Ila) and "very abnormal" (Class Ilb) values. In so doing, any NCV value 10 m/s below the lower limit of the abnormal range or unobtainable NCV was segregated into Class IIb as were CPT values greater than 9 mAmp and VTs greater than 35 volts. The repeat contrast analysis did show significant differences in PS values between Class I and Class IIb for NCSMED, NCVPER, NCSS, VTAR, and VTIB, but not for the SS values (figs I and 2). Class IIa NCVs showed no differences in SS and PS values from Class I NCVs, with the sole exception of NCVM. In contrast, Class hIa CPTs in almost all cases showed significant differences in both SS and PS from Class I CPTs (figs I and 2).
Discussion
Nerve conduction testing is currently the standard procedure for diagnostic evaluation of diabetic neuropathy. The clinical question usually addressed by nerve conduction testing is whether or not diabetic neuropathy is present, and this technique has been effective in answering the question.' A far more subtle issue is whether nerve conduction velocities correlate sufficiently to the level of clinical impairment to furnish a quantitative indicator useful for comparison and follow up, in particular for the evaluation of sensory abnormalities.
The greatest difficulty in study design to evaluate this issue lies in the ability to define "clinical severity" of sensory neuropathy. Motor impairment is somewhat easier to define objectively than abnormal sensation. The NSS and NDS scoring system relies on a preponderant contribution of motor rather than sensory assessments.47 In the present study, clinical evaluation of sensory function was the main emphasis. This clinical evaluation was then systematically categorised and stratified by both neurological history and physical examination data, evaluated separately. Careful and thorough quantitation of symptom evaluation and neurological physical exam was essential. Historical data are quite subjective, conditioned by patient as well as interviewer perception. Very painful diabetic neuropathy may justifiably be perceived as "severe", but is it more severe than asymptomatic anesthaesia below the knees and elbows? We attempted to establish historical criteria to minimise variability. Furthermore, the physical examination was carried out in highly structured, reproducible fashion, on a large number of anatomic sites, with a well defined categorisation procedure. Electrodiagnostic testing is also subject to significant variability. Nerve conduction testing was repeated within several days of each test, whenever possible, to minimise variability. Perhaps the most substantial safeguard against subjective and procedural variations was the repeated serial evaluations of a significant percentage of the study subjects.
Having taken these steps to improve the quality of the quantitative comparisons, our results suggest that NCVs are far from an ideal parametric indicator in diabetic sensory neuropathy. Although the correlations between detailed historical and physical scoring and most NVCs are significant, the degrees of correlation do not appear sufficient to create adequate distinctions among the various strata of clinically observable impairment. Indeed, the first level of contrast is between the normal and abnormal range of NCVs. Here, with the relative exception of the median nerve motor nerve conduction velocity, most NCVs failed to provide significant clinical distinctions.
Similar findings have been reported by other investigators. Halar and associates found no difference in median sensory, sural sensory, and tibial motor NCVs between diabetics with and without clinical signs of diabetic neuropathy. 47 Lamontagne and Buchthal found a significant correlation between clinical signs and symptoms and peroneal nerve motor nerve conduction velocities, but not with median nerve motor or sensory NCVs. 4 Dyck et al have found significant correlations between NCVs and NSS and NDS scores."849 The levels of correlation they reported have been somewhat higher than in the present study, particularly for the symptom scoring using the NSS, perhaps reflecting the very high contribution of motor abnormalities to the NSS and NDS system they use. Nevertheless, the levels of correlation have likewise been insufficient for specific clinical gradation. For example, they reported that abnormality of nerve conduction of a single nerve is associated with only 26% abnormality of NSS 
